General Information on Innohep
Innohep, with active ingredient tinzaparin sodium is a blood thinning drug (anticoagulant). It is used in conjunction with another blood thinner, warfarin, to treat DVT (deep vein thrombosis), a severe blood clot that can cause blood clotting in the lungs.
The generic name of Innohep is Tinzaparin. It works by blocking the production of certain chemicals that are responsible for blood clotting. Innohep is administered via a subcutaneous injection. Innohep is not meant for intramuscular or intravenous administration.
Side effects of Innohep
Innohep, like other drugs may cause certain side effects. In fact in some cases, this drug may cause potentially dangerous side effects. That is why, before you start treatment, discuss the risks of Innohep present to you with your doctor.
Common side effects of Tinzaparin may include: back pain, headache, dizziness, constipation, diarrhea, irritation, swelling, or mild pain at the injection site, sleep problems, chest pain, or vision or speech problems.
In addition to the above, Innohep may also cause: burning sensation or pain during urination, severe headache, easy bruising, easy or unusual bleeding, black stools, vomit that appears like coffee grounds or coughing up blood, or muscle weakness.
You should not buy Innohep if you have a known allergy to tinzaparin, sulfites, heparin, pork products, or benzyl alcohol. An allergic reaction to the drug may lead to severe swelling of the skin around the injection site, itching of the skin, or hives. In case of a severe allergy reaction, the patient may experience trouble breathing or swallowing and may require hospitalization. If you are using this drug for the first time and experience any symptoms associated with allergy reaction (skin rashes, skin itching, hives, facial flushing, swelling of the throat, lips, or tongue, wheezing, or trouble breathing or swallowing), consult your doctor immediately.
Innohep is contraindicated in patients who have an active bleeding. To ensure that this drug is safe for you, inform your doctor about your medical history.
The administration of Tinzaparin in pregnant women should only be considered if the expected benefit to the mother is greater than any possible risk to the unborn child.
The safety of Innohep in breastfeeding women is not known. The contents of this drug may enter breast milk and cause harm to a nursing child. If you are breastfeeding, it is best that you consult a doctor before you buy Innohep.
Dosage of Innohep
This drug is available in form of multiple dosage Innohep 2 mL vials. The recommended dosage for DVT is 175 anti-Xa IU/kg administered subcutaneously once per day for a minimum period of 6 days.
Interactions
During treatment with Innohep, you must be careful about what other drugs you take. Certain drugs when used with this blood thinner may lead to serious complications. Names of some drugs that, when taken with Innohep, may significantly increase your risk to easy bleeding are: heparin, dalteparin, salicylates, argatroban, dextran, NSAIDs, alteplase, urokinase, clopidogrel, cilostazol, or prasugrel.
This is not a complete list of drugs that may interact with Innohep. To ensure that you do not experience any dangerous drug interactions, inform your doctor, prior to using Innohep, about all other drugs that you are taking.
